Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer

被引：0
|
作者：
Muller, Marius [1 ]
Battisti, Umberto [1 ]
Shalgunov, Vladimir [1 ]
Jorgensen, Jesper [1 ]
Hvass, Lars [1 ]
Kramer, Vasko [2 ]
Kjaer, Andreas [1 ]
Herth, Matthias [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
[2] Positronpharma SA, Santiago, Chile
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
BREAST-CANCER; TRASTUZUMAB; METASTASES; ONCOGENE;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-287
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [31] Further characterisation of the PET radiotracer for the serotonin transporter 11C-DASB.
    Wilson, AA
    Ginovart, N
    Hussey, D
    Houle, S
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 209P - 209P
  • [32] HER2-targeting ADC containing cleavable linker for targeted therapy of HER2-positive gastric cancer.
    Shin, S.
    Park, Y.
    Park, S.
    Ju, E.
    Ko, E.
    Chung, C.
    Song, S.
    Jeong, S.
    Choi, E.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [33] Improved synthesis of SV2A targeting radiotracer [11C]UCB-J
    Rokka, Johanna
    Schlein, Eva
    Eriksson, Jonas
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2019, 4 (01)
  • [34] Identification of novel genes and pathways involved in resistance to HER2-targeting agents in breast cancer
    Wetterskog, Daniel
    Shiu, Kai-Keen
    Chong, Irene
    Meijer, Titia
    Natrajan, Rachael
    Lord, Christopher J.
    Ashworth, Alan
    Reis-Filho, Jorge S.
    CANCER RESEARCH, 2011, 71
  • [35] Synergistic Antitumor Effect of S-1 and HER2-Targeting Agents in Gastric Cancer with HER2 Amplification
    Tanizaki, Junko
    Okamoto, Isamu
    Takezawa, Ken
    Tsukioka, Sayaka
    Uchida, Junji
    Kiniwa, Mamoru
    Fukuoka, Masahiro
    Nakagawa, Kazuhiko
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1198 - 1207
  • [36] Improved synthesis of SV2A targeting radiotracer [11C]UCB-J
    Johanna Rokka
    Eva Schlein
    Jonas Eriksson
    EJNMMI Radiopharmacy and Chemistry, 4
  • [37] GBR1302-BEAT® bispecific antibody targeting CD3 and HER2 demonstrates a higher anti-tumor potential than current HER2-targeting therapies
    Back, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential PET tumor imaging agent
    Fei, Xiangshu
    Zheng, Qi-Huang
    Liu, Xuan
    Wang, Ji-Quan
    Stone, K. Lee
    Miller, Kathy D.
    Sledge, George W.
    Hutchins, Gary D.
    1600, John Wiley and Sons Ltd (46):
  • [39] Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential PET tumor imaging agent
    Fei, XS
    Zheng, QH
    Liu, X
    Wang, JQ
    Stone, KL
    Miller, KD
    Sledge, GW
    Hutchins, GD
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (04): : 343 - 351
  • [40] HER2-targeting [68Ga]Ga-ABY-025 PET Predicts Early Metabolic Response in Metastatic Breast Cancer
    Alhuseinalkhudhur, A.
    Lindman, H.
    Liss, P.
    Sundin, T.
    Frejd, F. Y.
    Hartman, J.
    Iyer, V.
    Feldwisch, J.
    Lubberink, M.
    Ronnlund, C.
    Tolmachev, V.
    Velikyan, I.
    Sorensen, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S264 - S264
12345